Takeda Joins 5th ADC Summit to Discuss ADCETRIS Development

SMi reports (05.02.2016, London UK) ADCETRIS Global Medical Lead joins expert speaker panel at the 5th annual ADC Summit in London.

London, United Kingdom, February 10, 2016 --(PR.com)-- SMi is pleased to announce that Ashish Gautam, Global Medical Lead - ADCETRIS from Takeda, has joined the expert speaker line-up at the 5th annual ADC Summit taking place on 23 - 24 May in London, UK. Registration to the conference is now live on http://www.adcsummit.com/prcom with a special discount of £400 for bookings before 29 February.

Ashish will be opening Day Two of the conference with a keynote address entitled "ADCETRIS developed to treat Hodgkin Lymphoma" and will explore:

Development of ADCETRIS - the Takeda and Seattle Genetics alliance
Exploring the mechanism pathway of ADCETRIS
Data published to date from ADCETRIS registration studies
Ongoing ADCETRIS clinical development

Join industry leaders they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

Other presentations include:

Challenges and lessons learnt in ADC CMC development and outsourcing
Jens Lorhmann, Senior Global Program Manager, Novartis
Advancement in antibody grug conjugates: a step closer to magic bullets in war against cancer
Rakesh Dixit, Vice President, R&D, Medimmune
Impact of drug loading on ADC target binding and cytotoxicity
Debbie Meyer, Senior Principal Scientist, Pfizer
Predicting tissue distribution and clearance of antibody formats to improve selectivity of targeted therapies
Ben-Fillippo Krippendeorff, Principal Scientist, Roche
The design, synthesis and scale-up of an ADC tubulysin
Jeremy Parker, Principal Scientist, Pharmaceutical Development, AstraZeneca and many more.

The full speaker lineup can be found on http://www.adcsummit.com/prcom.

In addition to the conference, the event will feature two exclusive half-day post-conference workshops held on the 25 May 2016:

ADC payloads: Availability and mechanisms of action
Hosted by Femtogenix and King’s Cross London
Developments in high potency API manufacturing
Hosted by SKAN AG

For more information or to register visit the event website at www.adcsummit.com/prcom.

To take advantage of the Early Bird Offer, register before 29 February to save £400 off the conference price.

For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
For delegate bookings contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk
For media enquiries contact Honey de Gracia on +44 (0) 20 7827 6102 or email hdegracia@smi-online.co.uk

5th ADC Summit
23-24 May 2016
London, UK
Contact e-mail: hdegracia@smi-online.co.uk
Contact number: +44 (0) 207 827 6102
Event Website: www.adcsummit.com/prcom
Contact
SMi Group
Honey de Gracia
+44 (0) 207 827 6054
http://www.clinical-trial-logistics.com/prcom
ContactContact
Categories